References
Holst, F. et al. Nat. Genet. 39, 655–660 (2007).
Chin, S.F. et al. Oncogene 26, 1959–1970 (2007).
Isola, J. et al. Clin. Cancer Res. 5, 4140–4145 (1999).
Nessling, M. et al. Cancer Res. 65, 439–447 (2005).
Bergamaschi, A. et al. Genes Chromosom. Cancer 45, 1033–1040 (2006).
Tibshirani, R. & Wang, P. Spatial smoothing and hot spot detection for CGH data using the fused lasso. Biostatistics 9, 18–29 (2007).
Nordgard, S.H. et al. Genes Chromosom. Cancer 47, 680–696 (2008).
Lingjaerde, O., Baumbusch, L., Liestol, K., Glad, I. & Borresen-Dale, A. Bioinformatics 21, 821–822 (2005).
Al Kuraya, K. et al. Cancer Res. 64, 8534–8540 (2004).
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Note and Supplementary Table 1 (PDF 145 kb)
Rights and permissions
About this article
Cite this article
Horlings, H., Bergamaschi, A., Nordgard, S. et al. ESR1 gene amplification in breast cancer: a common phenomenon?. Nat Genet 40, 807–808 (2008). https://doi.org/10.1038/ng0708-807
Issue Date:
DOI: https://doi.org/10.1038/ng0708-807
- Springer Nature America, Inc.
This article is cited by
-
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
Breast Cancer Research and Treatment (2019)
-
Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer
Breast Cancer Research and Treatment (2015)
-
ESR1 gene amplification: another mechanism regulating the cellular levels of ERα
Nature Reviews Cancer (2011)
-
Not enough evidence to include ESR1 amplification
Nature Reviews Cancer (2011)
-
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study
Cellular Oncology (2011)